Tests

1st tests to order

urinalysis

Test
Result
Test

Proteinuria will result in dipstick positive for protein.

Result

positive for protein; bland sediment, lipid droplets occasionally

urine protein to creatinine ratio

Test
Result
Test

Spot urine test may be performed initially. This may be followed by a 24-hour urine collection in uncertain cases.

Result

>3.5 is consistent with nephrotic syndrome

serum BUN

Test
Result
Test

Abnormal suggests renal dysfunction and will help guide treatment.

Result

normal or elevated

serum creatinine

Test
Result
Test

Elevation suggests renal impairment. Value can be used to calculate the creatinine clearance.

Result

normal or elevated

creatinine clearance

Test
Result
Test

Calculated from the serum creatinine when age, sex, and ethnicity are taken into account. [ Glomerular Filtration Rate Estimate by the IDMS-Traceable MDRD Study Equation Opens in new window ]

Result

normal or decreased

serum albumin

Test
Result
Test

Hypoalbuminemia of <3 g/dL is consistent with nephrotic syndrome.

Result

usually low

lipid profile

Test
Result
Test

Hyperlipidemia is seen in nephrotic syndrome due to increased synthesis by the liver and urinary loss of lipid-regulating proteins.

Result

normal or elevated

Tests to consider

serum or plasma LFTs

Test
Result
Test

Abnormal may suggest underlying hepatitis B or C.

Result

elevated with hepatitis

hepatitis B and C serology

Test
Result
Test

Acute or chronic infection can be associated with MN.

Result

positive with hepatitis infection

antinuclear antibody, antidouble-stranded DNA

Test
Result
Test

High titers suggest underlying systemic lupus erythematosus (SLE).

Result

elevated in SLE

complement levels

Test
Result
Test

Typically C3, C4, CH50.

Result

low in SLE

anti-SS-B, anti-SS-A

Test
Result
Test

Sjogren syndrome may cause secondary MN.

Result

positive in Sjogren syndrome

anti-PLA2R autoantibodies

Test
Result
Test

A high proportion of patients with primary MN have circulating antibodies to M-type phospholipase A2 receptor (PLA2R), a transmembrane protein located on podocytes.[8][9]​​

PLA2R appears to be a major antigen in the pathogenesis of primary MN in humans.

A positive test for anti-PLA2R autoantibodies does not rule out secondary causes, such as hepatitis or lupus.

Result

positive test is suggestive of primary MN

anti-Thrombospondin type 1 domain–containing 7A (THSD7A) autoantibodies

Test
Result
Test

About 10% of patients with primary MN have antibodies circulating autoantibodies to THSD7A but not to PLA2R.[19]​​

Result

positive test is suggestive of primary MN

renal ultrasound with renal artery Doppler study

Test
Result
Test

Helps to exclude other pathologies and causes of renal dysfunction.

Specifically, ultrasound is useful to assess the size of the kidneys to rule out hydronephrosis; evaluate systolic arterial pressures to rule out renal artery stenosis; and evaluate resistive indices for microvascular disease.

Result

variable

renal biopsy

Test
Result
Test

Referral to specialist for consideration of renal biopsy. Definitive diagnosis based on biopsy findings; the most sensitive and specific test.

Light microscopy: diffuse thickening of glomerular basement membrane (GBM) throughout all glomeruli in absence of significant hypercellularity.

Immunofluorescence microscopy: diffuse granular pattern of IgG, with C3 along GBM.

Electron microscopy: stage 1: light microscopy normal; small electron-dense subepithelial deposits with segmental distribution; focal foot process effacement is a constant. Stage 2: subepithelial electron-dense deposits with small GBM extensions (spikes); GBM spikes seen with silver staining (segments of GBM between dense deposits). Stage 3: dense deposits are incorporated in GBM; thickening of GBM detectable by light microscopy. Stage 4: markedly thickened GBM with initial electron-dense deposits now electron lucent.[21]​​

Result

characteristic changes with light, immunofluorescence, and electron microscopy

Use of this content is subject to our disclaimer